A comparison of postoperative outcomes after open and laparoscopic reduction of Petersen's Hernia: a multicenter observational cohort study.
Gastric neoplasm
Internal hernia
Laparoscopy
Petersen’s hernia
Journal
BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567
Informations de publication
Date de publication:
15 Apr 2021
15 Apr 2021
Historique:
received:
28
10
2020
accepted:
08
04
2021
entrez:
16
4
2021
pubmed:
17
4
2021
medline:
20
4
2021
Statut:
epublish
Résumé
The aim of this multicenter cohort study was to compare the clinical courses between open and laparoscopic Petersen's hernia (PH) reduction. We retrospectively collected the clinical data of patients who underwent PH repair surgery after gastrectomy for gastric cancer from 2015-2018. Forty patients underwent PH reduction operations that were performed by six surgeons at four hospitals. Among the 40 patients, 15 underwent laparoscopic PH reduction (LPH), and 25 underwent open PH reduction (OPH), including 4 patients who underwent LPH but required conversion to OPH. We compared the clinical factors between the LPH and OPH groups. In the clinical course, we found no differences in operation times or intraoperative bowel injury, morbidity, or mortality rates between the two groups (p > 0.05). However, the number of days on a soft fluid diet (OPH vs. LPH; 5.8 vs. 3.7 days, p = 0.03) and length of hospital stay (12.6 vs. 8.2 days, p = 0.04) were significantly less in the LPH group than the OPH group. Regarding postoperative complications, the OPH group had a case of pneumonia and sepsis with multi-organ failure, which resulted in mortality. In the LPH group, one patient experienced recurrence and required reoperation for PH. Laparoscopic PH reduction was associated with a faster postoperative recovery period than open PH reduction, with a similar incidence of complications. The laparoscopic approach should be considered an appropriate strategy for PH reduction in selected cases.
Sections du résumé
BACKGROUND
BACKGROUND
The aim of this multicenter cohort study was to compare the clinical courses between open and laparoscopic Petersen's hernia (PH) reduction.
METHOD
METHODS
We retrospectively collected the clinical data of patients who underwent PH repair surgery after gastrectomy for gastric cancer from 2015-2018. Forty patients underwent PH reduction operations that were performed by six surgeons at four hospitals. Among the 40 patients, 15 underwent laparoscopic PH reduction (LPH), and 25 underwent open PH reduction (OPH), including 4 patients who underwent LPH but required conversion to OPH.
RESULTS
RESULTS
We compared the clinical factors between the LPH and OPH groups. In the clinical course, we found no differences in operation times or intraoperative bowel injury, morbidity, or mortality rates between the two groups (p > 0.05). However, the number of days on a soft fluid diet (OPH vs. LPH; 5.8 vs. 3.7 days, p = 0.03) and length of hospital stay (12.6 vs. 8.2 days, p = 0.04) were significantly less in the LPH group than the OPH group. Regarding postoperative complications, the OPH group had a case of pneumonia and sepsis with multi-organ failure, which resulted in mortality. In the LPH group, one patient experienced recurrence and required reoperation for PH.
CONCLUSION
CONCLUSIONS
Laparoscopic PH reduction was associated with a faster postoperative recovery period than open PH reduction, with a similar incidence of complications. The laparoscopic approach should be considered an appropriate strategy for PH reduction in selected cases.
Identifiants
pubmed: 33858393
doi: 10.1186/s12893-021-01200-8
pii: 10.1186/s12893-021-01200-8
pmc: PMC8051092
doi:
Types de publication
Case Reports
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
195Références
Case Rep Surg. 2017;2017:5948962
pubmed: 28409048
Ann Intern Med. 2006 Apr 18;144(8):575-80
pubmed: 16618955
Gastric Cancer. 2014 Jan;17(1):146-51
pubmed: 23558458
J Gastric Cancer. 2019 Mar;19(1):1-48
pubmed: 30944757
J Clin Oncol. 2016 Apr 20;34(12):1350-7
pubmed: 26903580
Lancet Oncol. 2005 Jul;6(7):477-84
pubmed: 15992696
Ann Surg. 2016 Jan;263(1):28-35
pubmed: 26352529
Obes Surg. 2015 Apr;25(4):622-7
pubmed: 25218014
Lancet. 2016 Apr 2;387(10026):1397-1404
pubmed: 26895675
Gastric Cancer. 2019 Sep;22(5):1009-1015
pubmed: 30758761
Br J Surg. 2005 Jan;92(1):44-9
pubmed: 15584058